CNS Pharmaceuticals, Inc. CNSP
Set alert
5.00 USD +0.23 +4.82%
At close · Oct 30
5.00 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
4.25 Day range 5.00
2.13 52-week range 7.84
- YTD
- -4.76%
- 1 year
- -33.42%
- Open
- 4.60
- Prev close
- 4.77
- Mkt cap
- 7.31M
- Vol
- 52.92K
- Avg vol
- 8.37K
- EPS
- -17.90
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.25
- High
- 5.00
- Forward P/E
- -0.28
- Beta
- 1.05
- Short ratio
- 0.04
- Inst. own
- 0.79%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.11872
- 200-d avg
- 4.42
- 1y target
- 0.50
MAX chart
Events in this range
- Nov 29, 2022Split: 1 for 30
- Aug 14, 2023Earnings: -52; estimate 0; surprise —%
- Nov 14, 2023Earnings: -54; estimate 0; surprise —%
- Apr 1, 2024Earnings: -47.5; estimate 0; surprise —%
- May 15, 2024Earnings: -20.5; estimate 0; surprise —%
- Jun 5, 2024Split: 1 for 50
- Aug 14, 2024Earnings: -6.72; estimate 0; surprise —%
- Nov 14, 2024Earnings: -0.25; estimate 0; surprise —%
- Feb 21, 2025Split: 1 for 50
- Jul 22, 2025Split: 1 for 12
Signals (91)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 1 day ago |
| SMA: Bearish | Oct 26, 2026 | 6 days ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| RSI: Oversold | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| RSI: Oversold | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Dec 23, 2024 | 1 year ago |
| SMA: Bearish | Nov 25, 2024 | 1 year ago |
| SMA: Bullish | Nov 18, 2024 | 1 year ago |
| RSI: Oversold | Jun 17, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 18, 2024 | 2 years ago |
| MACD: Sell Signal | Dec 25, 2023 | 2 years ago |
| SMA: Bearish | Dec 11, 2023 | 2 years ago |
| SMA: Bearish | Dec 11, 2023 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 16, 2023 | 3 years ago |
| SMA: Bullish | Oct 16, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 16, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 18, 2023 | 3 years ago |
| SMA: Bearish | Aug 28, 2023 | 3 years ago |
| SMA: Bullish | Aug 21, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Aug 7, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| SMA: Bullish | May 15, 2023 | 3 years ago |
| SMA: Bearish | May 8, 2023 | 3 years ago |
| SMA: Bullish | Apr 10, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 2, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 26, 2022 | 3 years ago |
| SMA: Bearish | Nov 28, 2022 | 3 years ago |
| RSI: Oversold | Nov 28, 2022 | 3 years ago |
| SMA: Bullish | Nov 14, 2022 | 3 years ago |
| RSI: Oversold | Oct 17, 2022 | 4 years ago |
| RSI: Oversold | Sep 19, 2022 | 4 years ago |
| RSI: Oversold | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | Aug 22, 2022 | 4 years ago |
| RSI: Oversold | Aug 15, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Apr 4, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 21, 2022 | 4 years ago |
| RSI: Oversold | Nov 15, 2021 | 4 years ago |
| SMA: Bearish | Jun 28, 2021 | 5 years ago |
| SMA: Bullish | May 31, 2021 | 5 years ago |
| SMA: Bearish | Apr 5, 2021 | 5 years ago |
| MACD: Sell Signal | Apr 5, 2021 | 5 years ago |
| SMA: Bearish | Mar 22, 2021 | 5 years ago |
| SMA: Bullish | Mar 8, 2021 | 5 years ago |
| SMA: Bearish | Mar 1, 2021 | 5 years ago |
| SMA: Bullish | Feb 1, 2021 | 5 years ago |
| SMA: Bullish | Feb 1, 2021 | 5 years ago |
| MACD: Buy Signal | Feb 1, 2021 | 5 years ago |
| SMA: Bearish | Jan 25, 2021 | 5 years ago |
| MACD: Sell Signal | Jan 25, 2021 | 5 years ago |
| SMA: Bullish | Jan 18, 2021 | 5 years ago |
| SMA: Bearish | Dec 21, 2020 | 5 years ago |
| SMA: Bearish | Dec 21, 2020 | 5 years ago |
| SMA: Bullish | Nov 16, 2020 | 5 years ago |
| SMA: Bullish | Nov 2, 2020 | 6 years ago |
| SMA: Bearish | Sep 14, 2020 | 6 years ago |
| SMA: Bullish | Aug 24, 2020 | 6 years ago |
| SMA: Bearish | May 25, 2020 | 6 years ago |
| SMA: Bullish | May 4, 2020 | 6 years ago |
| SMA: Bearish | Apr 20, 2020 | 6 years ago |
| SMA: Bullish | Apr 6, 2020 | 6 years ago |
| RSI: Oversold | Mar 23, 2020 | 6 years ago |
| RSI: Oversold | Mar 9, 2020 | 6 years ago |
| SMA: Bearish | Feb 10, 2020 | 6 years ago |
Key statistics
- Market cap
- 6.27M
- Enterprise value
- 2.01M
- Trailing P/E
- 0.00
- Forward P/E
- -0.28
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -299.06
- Beta
- 1.05
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -5.19M
- Total cash
- 1.49M
- Total debt
- 123.25K
- Return on equity
- 0.00%
- Shares outstanding
- 57.49M
- Short % of float
- 2.79%
- 50-day average
- 0.11872
- 200-day average
- 4.42
Analyst view
Consensus: none
Price target (mean) 0.50
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
CNSP Revenue — quarterly 0
CNSP Net income — quarterly -2.59M
CNSP EPS — quarterly -0.38
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.25 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -6.72 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -20.50 | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -47.50 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -54.00 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -52.00 | — | — |
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. CNS Pharmaceuticals, Inc. has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- cnspharma.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CNSP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CLIMACO JOHN M | Chief Executive Officer | Purchase | Jan 31, 2024 | 215,676 |
| DOWNS CHRISTOPHER | Chief Financial Officer | Purchase | Jan 31, 2024 | 103,438 |
| EVANS CARL ANTHONY | Director | Purchase | Jan 31, 2024 | 33,458 |
| GUMULKA JERZY | Director | Purchase | Jan 31, 2024 | 43,006 |
| PRIEBE WALDEMAR PH.D. | Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 27, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.35% | 203,180 | 22.15K | Sep 29, 2024 |
| UBS Group AG | 0.32% | 181,866 | 19.82K | Sep 29, 2024 |
| Virtu Financial LLC | 0.21% | 122,876 | 13.39K | Sep 29, 2024 |
| Goldman Sachs Group Inc | 0.05% | 28,197 | 3.07K | Sep 29, 2024 |
| Jane Street Group, LLC | 0.04% | 23,160 | 2.52K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.03% | 16,298 | 1.78K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.28% | 162,183 | 17.68K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.07% | 37,943 | 4.13K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.00% | 1,168 | 127 | Sep 29, 2024 |
| Blackstone Alternative Multi-Strategy Fund | 0.00% | 8 | 0 | Sep 29, 2024 |